DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/828c7l/global_gastric) has announced the addition of the "Global Gastric Cancer Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Gastric Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Gastric Cancer market. It covers active Gastric Cancer pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Gastric Cancer - Disease Overview
2. Gastric Cancer Pipeline Overview
3. Gastric Cancer Phase 3 Clinical Trial Pipeline Insights
4. Gastric Cancer Phase 2 Clinical Trial Pipeline Insights
5. Gastric Cancer Phase 1 Clinical Trial Pipeline Insights
6. Gastric Cancer Preclinical Research Pipeline Insights
7. Gastric Cancer Discovery Stage Pipeline Insights
8. Gastric Cancer Drug Development Activities - Geographic Landscape
8.1. Gastric Cancer R&D Activities in North America
8.2. Gastric Cancer R&D Activities in Europe
9. Gastric Cancer Pipeline - Licensing Activities
Table 1. Gastric Cancer Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Gastric Cancer Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Gastric Cancer Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Gastric Cancer Pipeline Molecules - Preclinical Research
Table 5. Gastric Cancer Pipeline Molecules - Drug Discovery
Table 6. Gastric Cancer R&D Activities by Geography
Table 7. Gastric Cancer Pipeline Molecules - North America
Table 8. Gastric Cancer Pipeline Molecules - Europe
Table 9. Gastric Cancer Pipeline - Licensing Activities
Figure 1. Gastric Cancer Pipeline Molecules by R&D Stage
Figure 2. Gastric Cancer R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/828c7l/global_gastric